2023
DOI: 10.1097/mpg.0000000000003761
|View full text |Cite
|
Sign up to set email alerts
|

Postvaccination Immunogenicity of COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease: Comment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 4 publications
0
3
0
Order By: Relevance
“…Some of the studies in the literature related to ChatGPT have examined the responses given to typical patient questions [10], while others have investigated responses to questions directed towards healthcare professionals [11]. In this study, we examined ChatGPT's responses to both groups of questions.…”
Section: Discussionmentioning
confidence: 99%
“…Some of the studies in the literature related to ChatGPT have examined the responses given to typical patient questions [10], while others have investigated responses to questions directed towards healthcare professionals [11]. In this study, we examined ChatGPT's responses to both groups of questions.…”
Section: Discussionmentioning
confidence: 99%
“…We have read with interest the letter submitted by Amnuay Kleebayoon and Viroj Wiwanitkit. (1) In this letter, the authors raise the point that higher post‐vaccination levels of anti‐spike S2 antibodies in inflammatory bowel disease patients compared to controls could be explained by cross‐contamination with “silent COVID‐19 infection” in some of the subjects who had no apparent clinical signs at the time of testing.…”
Section: Dear Editormentioning
confidence: 98%
“…On behalf of our research team, I would like to submit a short response to the Letter to the Editor (“Postvaccination Immunogenicity of COVID-19 Vaccine in Pediatric Inflammatory Bowel Disease. : Comment”)( 1 ) concerning our original article published in JPGN named “Post-Vaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease.”( 2 )…”
Section: Dear Editormentioning
confidence: 99%